Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proceed
NCT04539951Phase 2Recruiting
- Sponsor
- Shanghai Mental Health Center
- Start
- Sep 2020
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sertraline, fluvoxamine, venlafaxine, memantine, aripiprazole in obsessive compulsive disorder (OCD), sponsored by Shanghai Mental Health Center. Started Sep 2020; status: recruiting.
02
Drugs
sertralinefluvoxaminevenlafaxinememantinearipiprazole
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04539951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539951.